Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROPINIROLE vs ROSIGLITAZONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROPINIROLE vs ROSIGLITAZONE: Safety Overview

Metric ROPINIROLE ROSIGLITAZONE
Total FAERS Reports 4,239 45,976
Deaths Reported 310 4,661
Death Rate 7.3% 10.1%
Hospitalizations 1,192 23,675
Average Patient Age 65.5 yrs 60.2 yrs
% Female Patients 56.7% 42.8%
FDA Approval Date Apr 10, 2009 Jan 25, 2013
Manufacturer SOLCO HEALTHCARE US, LLC N/A
Route ORAL N/A
Marketing Status Discontinued Discontinued